Long-Term Survival After Nasopharyngeal Carcinoma Treatment in a Local Prefecture-Level Hospital in Southern China

References

• Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609–e616. doi:10.1016/S2214-109X(16)30143-727470177
   PubMed Web of Science ®Google Scholar
• Wei KR, Yu YL, Yang YY, et al. Epidemiological trends of nasopharyngeal carcinoma in China. Asian Pac J Cancer Prev. 2010;11(1):29–32.20593926
   PubMedGoogle Scholar
• Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23(2):261–270. doi:10.1016/0360-3016(92)90740-91587745
   PubMed Web of Science ®Google Scholar
• Lee AW, Ng WT, Chan LL, et al. Evolution of treatment for nasopharyngeal cancer–success and setback in the intensity-modulated radiotherapy era. Radiother Oncol. 2014;110(3):377–384. doi:10.1016/j.radonc.2014.02.00324630534
   PubMed Web of Science ®Google Scholar
• Sun X, Su S, Chen C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110(3):398–403. doi:10.1016/j.radonc.2013.10.02024231245
   PubMed Web of Science ®Google Scholar
• Wang W, Feng M, Fan Z, Li J, Lang J. Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. Biomed Res Int. 2014;2014:814948.25162028
   PubMed Web of Science ®Google Scholar
• Chen X, Zhu X, Liang Z, et al. Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method. Onco Targets Ther. 2017;10:2909–2921. doi:10.2147/OTT.S13559028652773
   PubMed Web of Science ®Google Scholar
• Ng WT, Lee MC, Hung WM, et al. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2011;79(2):420–428. doi:10.1016/j.ijrobp.2009.11.02420452132
   PubMed Web of Science ®Google Scholar
• Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80. doi:10.1016/S0140-6736(19)30956-031178151
   PubMed Web of Science ®Google Scholar
• Cao CN, Luo JW, Gao L, et al. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma. Oral Oncol. 2013;49(2):175–181. doi:10.1016/j.oraloncology.2012.08.01323021729
   PubMed Web of Science ®Google Scholar
• Wang L, Guo Y, Xu J, et al. Clinical analysis of recurrence patterns in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Ann Otol Rhinol Laryngol. 2017;126(12):789–797. doi:10.1177/000348941773422929025277
   PubMed Web of Science ®Google Scholar
• Jiang F, Jin T, Feng XL, Jin QF, Chen XZ. Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: the Zhejiang Cancer Hospital’s experience. J Cancer Res Ther. 2015;11(Suppl 2):C179–C184. doi:10.4103/0973-1482.16818126506872
   PubMedGoogle Scholar
• Zhao W, Lei H, Zhu X, Li L, Qu S, Liang X. Investigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a retrospective analysis. Oncotarget. 2016;7(52):86914–86925. doi:10.18632/oncotarget.v7i5227894100
   PubMedGoogle Scholar
• Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006;64(1):57–62. doi:10.1016/j.ijrobp.2005.03.05715936155
   PubMed Web of Science ®Google Scholar
• Tham IW, Hee SW, Yeo RM, et al. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience. Int J Radiat Oncol Biol Phys. 2009;75(5):1481–1486. doi:10.1016/j.ijrobp.2009.01.01819386431
   PubMed Web of Science ®Google Scholar
• Tuan JK, Ha TC, Ong WS, et al. Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma. Radiother Oncol. 2012;104(3):305–311. doi:10.1016/j.radonc.2011.12.02822280806
   PubMed Web of Science ®Google Scholar
• Zhang MX, Li J, Shen GP, et al. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up. Eur J Cancer. 2015;51(17):2587–2595. doi:10.1016/j.ejca.2015.08.00626318726
   PubMed Web of Science ®Google Scholar
• Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60(5):1440–1450. doi:10.1016/j.ijrobp.2004.05.02215590175
   PubMed Web of Science ®Google Scholar
• Chen YP, Wang ZX, Chen L, et al. A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. Ann Oncol. 2015;26(1):205–211. doi:10.1093/annonc/mdu50725355717
   PubMed Web of Science ®Google Scholar
• Sun Y, Li WF, Chen NY, et al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a Phase 3, multicentre, randomised controlled trial. Lancet Oncol. 2016;17(11):1509–1520. doi:10.1016/S1470-2045(16)30410-727686945
   PubMed Web of Science ®Google Scholar
• Ren Y, Qiu H, Yuan Y, et al. Evaluation of 7th edition of AJCC staging system for nasopharyngeal carcinoma. J Cancer. 2017;8(9):1665–1672. doi:10.7150/jca.1919728775786
   PubMed Web of Science ®Google Scholar
• Liang ZG, Chen XQ, Niu ZJ, et al. Recommendations for updating T and N staging systems for nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy. PLoS One. 2016;11(12):e0168470. doi:10.1371/journal.pone.016847027973544
   PubMed Web of Science ®Google Scholar
• OuYang PY, Zhang LN, Tang J, et al. Evaluation of body mass index and survival of nasopharyngeal carcinoma by propensity-matched analysis: an observational case-control study. Medicine. 2016;95(2):e2380. doi:10.1097/MD.000000000000238026765414
   PubMed Web of Science ®Google Scholar
• Wu LR, Liu YT, Jiang N, et al. Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: an analysis of 614 patients from a single center. Oral Oncol. 2017;69:26–32. doi:10.1016/j.oraloncology.2017.03.01528559017
   PubMed Web of Science ®Google Scholar
• Lee AW, Tung SY, Ngan RK, et al. Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 trials. Eur J Cancer. 2011;47(5):656–666. doi:10.1016/j.ejca.2010.10.02621112774
   PubMed Web of Science ®Google Scholar
• Loong HH, Ma BB, Leung SF, et al. Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma. Radiother Oncol. 2012;104(3):300–304. doi:10.1016/j.radonc.2011.12.02222300609
   PubMed Web of Science ®Google Scholar
• Hui EP, Ma BB, Leung SF, et al. Randomized Phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Onco. 2009;27(2):242–249. doi:10.1200/JCO.2008.18.1545
   PubMed Web of Science ®Google Scholar
• OuYang PY, Zhang LN, Xiao Y, et al. Validation of published nomograms and accordingly individualized induction chemotherapy in nasopharyngeal carcinoma. Oral Oncol. 2017;67:37–45. doi:10.1016/j.oraloncology.2017.01.00928351579
   PubMed Web of Science ®Google Scholar
• Zhang LL, Zhou GQ, Li YC, et al. Induction chemotherapy has no prognostic value in patients with locoregionally advanced nasopharyngeal carcinoma and chronic hepatitis B infection in the IMRT era. Transl Oncol. 2017;10(5):800–805. doi:10.1016/j.tranon.2017.07.00128844018
   PubMed Web of Science ®Google Scholar
• Ai QY, King AD, Mo FKF, et al. Prediction of distant metastases from nasopharyngeal carcinoma: improved diagnostic performance of MRI using nodal volume in N1 and N2 stage disease. Oral Oncol. 2017;69:74–79. doi:10.1016/j.oraloncology.2017.04.00828559024
   PubMed Web of Science ®Google Scholar
• Huang JF, Sun RJ, Jiang WJ, et al. Systematic nutrition management for locally advanced nasopharyngeal carcinoma patients undergoing radiotherapy. Onco Targets Ther. 2019;12:8379–8386. doi:10.2147/OTT.S21378931632085
   PubMed Web of Science ®Google Scholar